Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
deals
5
×
life sciences
national blog main
national top stories
boston blog main
boston top stories
gene therapy
san francisco blog main
san francisco top stories
cancer
car-t
crispr
europe blog main
hemophilia
national
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
roche
san diego blog main
san diego top stories
san francisco
startups
vc
zolgensma
acquisitions
adeno-associated virus
administration
advanced therapies
alexandria venture investments
altitude life science ventures
alzheimer's
american society of gene and cell therapy
amgen
arch venture partners
atmp
avexis
What
therapy
5
×
gene
therapeutics
deal
medicine
access
advanced
approval
becker
betting
billion
billions
bio
biopharma
building
capacity
car
cell
consolidation
crispr
crude
cutting
despite
developer
disease
dollars
drug
duchenne
eaton
edge
effects
encoded
established
falcon
fda
firm
focus
healthcare
help
historic
Language
unset
Current search:
biotech
×
deals
×
therapy
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
